CIK 0001346830
- Non-accelerated filer
- Smaller reporting company
Tvardi Therapeutics, Inc.
Sign in to watch- Ticker
- TVRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 713-489-8654
- Business address
- 3 SUGAR CREEK CTR. BLVD., STE 525, SUGAR LAND, TX, 77478
- Former names
- Cara Therapeutics, Inc., Cara Therapeutics Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-17 | Alibhai Imran Nizamudin Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +182,320 | 182,320 | ||
| 2025-04-17 | Shiff Susan Ph.D. Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2025-04-17 | Wirk Shaheen Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2025-04-17 | WYZGA MICHAEL S Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2025-04-17 | Smith Cynthia Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2025-04-17 | Shah Sujal Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2025-04-17 | HALL WALLACE L JR Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2025-04-15 | HALL WALLACE L JR Director | Grant or award | +44,712 | 44,712 | ||
| 2025-04-15 | HALL WALLACE L JR Director | Grant or award | +202,044 | 202,044 | ||
| 2025-04-15 | Wirk Shaheen Director | Grant or award | +176,030 | 176,030 | ||
| 2025-04-15 | Wirk Shaheen Director | Grant or award | +263,164 | 263,164 | ||
| 2025-04-15 | O'Brien Stephen Paul Principal Accounting Officer | Grant or award · Employee Stock Option (right to buy) | +11,399 | 11,399 | ||
| 2025-04-15 | O'Brien Stephen Paul Principal Accounting Officer | Grant or award · Employee Stock Option (right to buy) | +3,352 | 3,352 | ||
| 2025-04-15 | HALL WALLACE L JR Director | Other acquisition | +44,712 | 44,712 | ||
| 2025-04-15 | HALL WALLACE L JR Director | Other acquisition | +202,044 | 202,044 | ||
| 2025-04-15 | Kauh John Saewook M.D. Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +74,049 | 74,049 | ||
| 2025-04-15 | WYZGA MICHAEL S Director | Grant or award · Stock Option (right to buy) | +18,441 | 18,441 | ||
| 2025-04-15 | Chen Yixin VP, Chem, Mfg and Ctrls | Grant or award · Employee Stock Option (right to buy) | +14,752 | 14,752 | ||
| 2025-04-15 | Wirk Shaheen Director | Grant or award | +4,191 | 4,191 | ||
| 2025-04-15 | Wirk Shaheen Director | Other acquisition | +176,030 | 176,030 |
Page 2 of 7 · 123 trades